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Summary 
We made double transgenic mice bearing immunoglobulin heavy and light chain genes encoding 
an autoantibody against the mouse erythrocyte by the cross of C57BL/6 mice carrying the transgene 
for each chain of the immunoglobulin. Although no obvious disorders were found in the single- 
chain transgenic mice, severely anemic symptoms were found in some of the double transgenic 
mice, in which most B cells express, at least on their surface, the autoantibody reactive to self- 
antigens  on the erythrocyte. Individual  double-transgenic  mice showed a wide variation  of 
phenotypes between severe anemia and no symptoms. Both deletion and anergy of autoreactive 
B cells were seen in each individual mouse, but their relative contribution to self-tolerance was 
variable and not directly related to the severity of anemia or the amount of the autoantibody 
produced. This transgenic system provides a good autoimmune disease model for exploring its 
onset mechanism,  and means of its  treatment and prevention. 
F 
Lunctional Ig genes are created by somatic DNA rearrange- 
ment of sub-exon DNA segments: V-D-J rearrangement 
for an H chain gene and V-J rearrangement for an L chain 
gene (1). Such a random genetic event on one hand contributes 
to amplification  of  limited germ-line repertoire of the Ig genes, 
but, on the other produces B cell antigen receptors that recog- 
nize and potentially react with self-components.  Without 
proper selection mechanisms, the immune system could not 
serve as an effective  defense mechanism for the organism. Au- 
toimmune diseases are, in a way, unwelcome byproducts of 
the sophistication  of our defense system. 
Clonal anergy and deletion of self-reactive B cells are two 
major mechanisms that have been postulated for donal selec- 
tion of self-reactive  B lymphocytes (i.e., self-tolerance). These 
mechanisms were demonstrated to be invoked for tolerance 
to self antigens in vivo using transgenic mouse models (2--4). 
Interestingly, however, the three transgenic models gave rise 
to apparently contrasting results. Goodnow et al. (2) estab- 
lished two lineages of transgenic mice. The first lineage has 
a transgene encoding an artificial self-antigen, hen egg lyso- 
zyme (HEL),  1 which is constitutively expressed under the 
control of the mouse metaUothionein I promoter. The other 
1 Abbreviations used in this paper: AIHA, autoimmune hemolytic anemia; 
HEL, hen egg lysozyme; MFI, mean fluorescence intensity. 
line contains the Ig H  and L chain genes encoding a high- 
affinity antibody specific  for HEL (both IgM and IgD). Splenic 
B  cells from mice of this  lineage  predominantly express 
transgene-derived IgM and/or IgD, the majority of which 
bind HEL. Double transgenic mice, derived by mating the 
two lineages, are indistinguishable from their littermates in 
the number and frequency of splenic B cells bearing the 
transgene-aUotype-positive IgM or in the number of HEIr 
binding B cells. However, splenic B cells from the double- 
transgenic mice are functionally silent. Similar self-tolerance 
mechanism, i.e., anergy of B cells without clonal deletion, 
was found in a transgenic line expressing an IgM antibody 
specific to single-stranded DNA (3). 
By contrast, Nemazee and Biirki (4) found that clonal de- 
letion of autoreactive B cell precursors takes place in another 
transgenic model, in which the H-2  d homozygous mice car- 
tying the Ig transgenes (both H and L chain genes) encoding 
an IgM antibody specific to the murine H-2  k MHC class I 
molecule are mated with H-2  k homozygous animals. These 
heterozygous animals (H-2  k  x  H-2  d) lack B cells bearing 
the anti-H-2  k idiotype and contain no anti-H-2  k antibody 
in the serum. 
The contrasting observations in the three transgenic lines 
were explained by difference of the nature of the antigens 
used as tolerogens (5). Cell surface antigens like H-2  k mol- 
ecules would facilitate extensive receptor crosslinking on de- 
veloping B cells, resulting in clonal deletion.  On the other 
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relatively low in concentrations would trigger anergic state 
of mature B cells. In addition to this discrepancy,  the previous 
transgenic models for B cell tolerance lack an essential fea- 
ture for understanding autoimmune diseases: breakage of toler- 
ance for the antigens and resultant pathological symptoms. 
We addressed this issue using transgenic mice that carry 
the Ig genes encoding an anti-murine erythrocyte autoanti- 
body derived from the hybridoma 4C8 (6). As the expres- 
sion of this autoantibody in animals causes autoimmune hemo- 
lytic anemia  (AIHA), we can easily correlate the onset of 
the autoimmune disease with deregulation of relevant autoreac- 
tive B cells (6, 7). Interestingly, the individual transgenic mice 
showed variable phenotypes ranging  from severe AIHA to 
complete tolerance. Furthermore,  the majority of the trans- 
genie mice showed partial  tolerance ascribed to both dele- 
tion  and anergy with  variable relative contributions. 
Materials  and Methods 
DNA Constructions.  The H chain transgene was constructed 
using DNA fragments described as follows. The 1.3-kb XhoI-NcoI 
fragment  containing  the promoter region and the initiation  site 
was isolated from pSV-V#I (8). The 0.4-kb  NcoI-EcoT14I frag- 
ment was isolated from eDNA encoding the H chain of the 4C8 
mAb (9). The 1.8-kb EcoT14I-EcoRI fragment containing the J.3, 
J,4 and enhancer sequences, and the 12-kb EcoRI-XhoI  fragment 
containing  the major intron and the C~ region derived from the 
genomic  clones Ch.M.Ig.#-18  (10) and  ),gtWES.IgH714  (11), 
respectively. The pSP72/73- (Promega Corp., Madison, WI) based 
plasmid containing the complete H chain gene (illustrated in Fig. 
1 A) was designated pMO-#4C8. For construction  of the L chain 
transgene, the 5.6-kb BamHI fragment extending from the pro- 
moter  to  the  C,  region  was  recloned  into  Bluescribe13(-) 
Stratagene  Inc.,  La Jolla,  CA).  This  plasmid  was  designated 
pMO-K4C8. 
Generation of Transgenic Mica  To generate H chain transgenic 
mice, the 15.5-kb XhoI fragment ofpMO-#4C8 was prepared and 
microinjected into fertilized eggs of C57BL/6 mice, followed by 
transfer of viable eggs into the oviducts of the pseudopregnant ICR 
mice according to Hogan et al. (12). L chain transgenic mice were 
generated similarly using the 5.6-kb BamHI fragment  of pMO- 
x4C8 as described above. Animals were obtained from Japan SLC 
Inc. (Hamamatsu, Japan). The presence of the transgenes was de- 
tected by Southern blot analysis (13, 14) with the probes presented 
in Fig. 1. Unless otherwise stated, experimental data were gener- 
ated using age-matched transgenic and wild-type control animals 
5-8 wk of age. 
RNase Protection Analysis.  To generate the antisense probe for 
detection of microinjected H chain transgene-specific mRNA, the 
485-bp HindlII fragment derived from pMO-#4C8 was subcloned 
into pSP72 and designated pMO-V~-4cs. As with L chain trans- 
gene, the 222-bp KpnI-KsaI  fragment derived from pMO-K4C8 
was subcloned into pGEM-4 (Promega Corp.) and designated pMO- 
Vg-4cs. Total RNA was prepared by the procedure of Chirgwin 
et al. (15). Experimental procedure was performed as described (16). 
Flow Cytometry.  Single-ceU suspensions from spleen, lymph 
node, bone marrow,  thymus,  or peritoneal cavity were deprived 
of erythrocytes by lysis in 0.83% NH4C1 solution,  stained with 
the appropriate  antibodies,  and analyzed by flow cytometry on 
FACScan  |  (Becton Dickinson & Co., Mountain  View, CA) after 
exclusion of dead cells by propidium iodide gating. The percentage 
of positively stained cells was calculated on the basis of cutoffs set 
by control experiments.  Indirect fluorescence staining was done 
as foUows: (a) staining with unconjugated  rat anti-mouse B220 
(RA3-6B2) (17) and anti-mouse MAC-1 (M1/70.15.11.5.HL ATCC 
TIB  128) mAbs was followed by the addition  of FITC-mouse 
anti-rat • mAb (MARK1; Immunotech S.A., France); (b) staining 
with biotinylated goat anti-mouse IgM (Zymed Laboratories Inc., 
San Francisco, CA) and anti-Id mAb ($54) was followed by the 
addition of PE-streptavidin (Becton Dickinson & Co.); (c) staining 
with biotinyhted anti-mouse  IgM' mAb (DS-1) (18) was followed 
by the addition of PE-streptavidin. Biotinylation was done using 
sulfosuccinimidyl-6-(biotinamido)-hexanoate (Pierce Chemical Co., 
Rockford,  IL)  according  to Harlow and Lane (19). FITC-goat 
anti-mouse IgM (Cappel Laboratories, West Chester, PA) and FITC- 
anti-mouse  IgM  b mAb  (MB86)  (20) were  used for the direct 
staining procedure. Each staining was performed in much excess 
of mouse monoclonal IgG1 and IgG2b (Cappel Laboratories) to 
block Fc receptors on cells. To estimate autoantibodies on autolo- 
gous erythrocytes, blood was collected by puncture  of the retro- 
orbital venous plexus of the eye with a heparinized capillary tube 
and washed in PBS solution twice. Erythrocytes were stained with 
FITC-goat  anti-mouse IgM (Cappel Laboratories) and analyzed 
on FACScan  | 
In Vitro Antibody Secretion and ELISA S~tera.  Spleen  cells were 
cultured  in the medium described before (16) in the presence of 
50/zg/ml LPS (Salmonella minnesota), 2 gg/ml Con A, or 10 #g/ml 
PHA (Sigma Chemical Co., St. Louis, MO) for 3 or 7 d in flat- 
bottomed microculture  phtes at 37~  in 5% humidified CO2. 
Secreted antibodies in the medium  of duplicate wells were mea- 
sured by solid-phase ELISA using goat anti-mouse IgM (Cappel 
Laboratories) or anti-Id  as the coating  antibody  and alkaliphos- 
phatase-conjugated goat anti-mouse IgM (Tago, Inc., Burlingame, 
CA) as the second antibody according to Harlow and Lane (19). 
Generation of  Anti-ldraAh  Anti-Id mAbs to the 4C8 mAb were 
obtained as described previously (21) with slight modification. In 
brief, spleen cells from BALB/c mice immunized  with the 4C8 
mAb coupled to KLH were fused with mydoma X63AgS.653 cells. 
Hybridoma supematants  were tested for the production  of mAb 
to the 4C8 mAb and polyclonal IgM from NZW sera by ELISA. 
Three hybridomas secreting mAbs that reacted to the 4C8 mAb 
but did not react to polyclonal NZW IgM were selected. These 
mAbs were tested for staining of spleen ceils from H3 mouse, L1 
mouse, or the hybridoma 4C8 to identify a mAb that can recog- 
nize the idiotope formed by the combination  of both the H and 
the L chains of the 4C8 mAb. Among these mAbs only the anti-Id 
mAb ($54) could react with the 4C8 hybridoma to the same ex- 
tent as goat anti-mouse IgM (Cappel), but stained no more than 
0.7% of spleen cells from H3 and L1 mice. 
Results 
Production of Transgenic Mice Containing the Ig Genes of the 
4C8 mAb and Their Expression.  The H  and L chain genes 
represented in Fig. 1 were injected separately into C57BL/6 
fertilized eggs for fear that expression of the antierythrocyte 
autoantibodies might cause severe AIHA, resulting in still- 
births. Seven lines of H chain and two lines of L chain trans- 
genie mice were established. We extensively investigated, as 
representative lines,  ARH3 (or H3) and ARL1 (or L1) of 
H  and L chain transgenic  mice, respectively. But all other 
lines of each transgene showed similar properties.  Line H3 
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jected Ig genes and their expression. 
(A) 4C8 H chain gene.  (B) 4C8 L 
chain gene. Coding regions and un- 
translated regions  are  represented  by 
open boxes. Probes for RNase pro- 
tection are shown below with ex- 
pected  protection  bands. Arrows in- 
dicate regions of probes used for 
Southern blotting analyses.  Relevant 
restriction  sites  are  shown:  B, 
BamHI; N, Nco I; E, F.coP, I; T, 
EcoT14I; X, Xho I; K, Kpn I; H, 
Hind III; R, P,  sa I. A site in a linker 
is  shown  with  a bracket.  RNase 
protection assay in (C) H3 mouse; 
(D) L1 mouse; and (E and F) H3L1 
mouse. Each lane contained 2.5/~g 
of total RNA. The 485 base-band 
is due to unspliced mRNA. Origin 
of RNA: lane 1, no RNA without 
digestion;  lane  2,  brain;  lane  3, 
lymph node; lane 4, heart; lane 5, 
lung; lane 6, thymus; lane 7, spleen; 
lane 8, liver; lane 9, kidney; lane 10, 
bone marrow; lane 11, muscle; lane 
12,  4C8 hybridoma. 
was bred from a female founder carrying about 10 copies of 
the H chain transgene at a single locus in an autosome, while 
line L1 was bred from a male founder bearing about twenty 
copies of the L chain transgene at a single locus in an auto- 
some. These transgenes were stably inherited as long as we 
checked by Southern blotting analysis (data  not shown). 
RNase protection analyses  were performed to test the tissue- 
specific expression of the transgenes.  We detected transgene- 
specific expression by using riboprobes complementary  to the 
V. and VL sequences (Fig.  1, C  and D). As expected,  both 
H and L transgenes were expressed only in lymphoid tissues 
such as lymph nodes, thymuses, spleens and bone marrows. 
Expression in the thymus was weaker than that in the spleen 
and lymph node in both transgenic mice. No detectable pro- 
tected bands were detected in lymphoid KNA from normal 
C57BL/6  mice (data  not  shown).  FAGS  |  analysis clearly 
showed that no surface Ig were found on T  cells (data not 
shown). 
Both H and L  Chain Genes of the Endogenous Loci Are Ex- 
cluded.  To determine whether expression of endogenous Ig 
H  and L chain genes is excluded by the transgenes, we ana- 
lyzed the spleen calls of H3 and L1 mice by FAGS  |  To stain 
the H chain we used anti-IgM antibody and antiallotypic rnAbs 
(DS-1 for IgM" and MB86 for IgMb). IgM +  , IgM  '+  (tram- 
genic), and IgM  b+  (endogenous) B cells were 39, 38,  and 
0.9%, respectively, of the total spleen cells derived from an 
H3 mouse (data  not shown). This means that only about 
2.5% orB cells express endogenous H chain genes, indicating 
that the endogenous H  chain genes are almost completely 
excluded by expression  of the H  chain transgene. 
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As the allotypic specificity for the L chain is not known, 
we cannot estimate the degree of allelic exclusion in L1 mice. 
However, strong alldic exclusion appeared  to be accom- 
plished for the endogenous H and L chain genes since almost 
all surface IgM on spleen B cells of H3  x  L1 double-transgenic 
(H3L1)  mice expressed the transgene Id, which is formed 
by the combination of the H and L chains of the 4C8 mAb 
and recognized by the $54 mAb (Fig. 2 A). Very few spleen 
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Figure  2.  Alhlic  e~lusion  in  H3LI 
mouse.  Spleen cells  were  stained 
doubly  with either  (.4)  anti-lgM  or 
(B) MB86 mAb, and anti-ld  mAb 
($54).  Contour  maps  show  correlated 
fluorescence in  arbitrary  relative 
fluorescence  units.  Percentages  of  posi- 
tively  stained  cells  were indicated  in 
each  compartment. B cells expressed endogenous allotype-specific IgM which did 
not carry the idiotype of the transgenes (Fig.  2 B).  Serum 
IgM of normal C57BL/6 mice was 2,400  _+  853 (/~g/ml) 
(mean +  SD of 10 mice), whereas that of H3L1 mice was 
143  _+  71 (/zg/ml) (mean  _+  SD of 18 mice) by ELISA in 
agreement with strong allelic exclusion. 
AIHA in H3LI Mice.  We examined whether H3L1 mice 
which should carry B cells reactive to autologous erythro- 
cytes  suffer  from AIHA.  Items of (heterozygous H3  x 
L1)F~ 428 mice examined were as follows:  H3L1, 91 mice; 
H3, 119 mice; L1, 101 mice; nontransgenic, 117 mice. This 
distribution excludes the possibility that we analyzed a selected 
population of H3L1 mice that had escaped from stillbirths 
due to overexpression  of the autoantibodies. Expression of 
the transgenes in the H3L1 mice was limited to lymphoid 
organs as described for the single-chain-transgenic mice, but 
the relative pattern of expression was different (Fig. 1, E and 
F). Expression of the transgenes in the spleen and bone marrow 
was greatly reduced probably because of clonal deletion and 
downregulation of surface IgM expression of autoreactive B 
cells as described below. 
We quantitated the amount of the autoantibody in H3L1 
mice, and found little free form in serum but considerable 
amounts associated with erythrocytes. We measured the he- 
matocrit values and the amounts of the autoantibody bound 
to erythrocytes by surface staining of erythrocytes with anti- 
IgM antibodies.  To our surprise,  wide variations  of the he- 
matocrit values and autoantibody amounts existed  among 
H3L1 individuals (Fig. 3 A). The mean fluorescence inten- 
sity (MFI), which is proportional to the amounts of the au- 
toantibodies associated with erythrocytes, spread in almost 
two-log range. Reverse correlation of the hematocrit values 
with MFI indicates  that the total amount of the autoanti- 
body produced directly correlates  with AIHA.  The result 
also implies that IgM associated with erythrocytes retains its 
original pathogenicity as well as bindability, and argues against 
the hypothesis that a large amount oflgM exists because these 
molecules have lost their pathogenicity probably by somatic 
mutation. In fact, some of these mice died of typical AIHA. 
We analyzed a number of H3 or L1 mice and did not find 
any signs of AIHA. Their hematocrit values were around 
45% at the age of 5-8 wk, and no autoantibodies were de- 
tected throughout their life in agreement with requirement 
of both chains of the antierythrocyte antibody for binding 
to erythrocytes. 
Based on the hematocrit values, we classified the H3L1 
transgenic mice into the three groups: the anemic type with 
hematocrit <30%; the tolerant type with hematocrit >40%; 
and the intermediate type with the intermediate hematocrit. 
Items of 79 mice analyzed were the anemic type, 5% (four 
mice); the intermediate type, 44% (35 mice); and the tolerant 
type, 51% (40 mice). Their typical staining patterns are shown 
in Fig. 3 C. The pedigree of H3L1 mice did not show any 
genetic or sexual bias among the three types (Fig. 4). Our 
preliminary data show that even a single mouse often changed 
the tolerance state, giving rise to an acute onset of AIHA 
from the state of complete tolerance, and vice versa (data not 
shown). The results dearly indicate that the effldency of toler- 
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Figure 3.  Various  phenotypes of H3L1 mice. (A) Reverse correlation 
of hematocrit values with amounts of autoantibodies on erythrocytes. 32 
H3L1 mice were analyzed by quantitating hematocrit values (vertical axis) 
and MFI of FITC-anti-IgM antibodies bound to erythrocytes (horizontal 
axis).  Each square represents one mouse. (B) Survival of 51Cr-labeled  syn- 
geneic erythrocytes in H3L1 mice. Erythrocyte survival study was done 
according to Cox et al. (22). The first sample was collected 24 h after 
injection and this value was taken as 100%. Subsequently, samples were 
collected at a 2-d interval. Closed circles, triangles, and squares represent 
normal C57BL/6, H3, and L1 mice, respectively. Open circles and tri- 
angles show the anemic and the intermediate types mice, respectively. (C) 
Erythrocytes were stained and analyzed as described in experimental proce- 
dures: solid line, the anemic type; fine stippled line, the intermediate type; 
broken line, the tolerant  type;  rough stippled line, normal C57BL/6. 
ance to the antierythrocyte autoantibody is variable among 
individuals in spite of the same genetic background. 
The half-life of StCr-labeled erythrocytes from the anemic 
type mice was half of those from the H3, L1, and normal 
C57BL/6 mice (Fig. 3 B). In addition, histological analysis 
￿9  the anemic  type  -]  (~ H3 
O the intermediate  type  |  TM  (~L1 
~) the tolerant  type  _j  O  no transgenes 
Figure 4.  A pedigree of H3L1 mice. Four generations of H3L1 mice 
were shown in a partial pedigree. The squares and circles represent males 
and females, respectively. All the H3L1 mice were described. Littermates 
other than H3L1 were included only when they were used for subsequent 
breeding.  Genotypes and phenotypes  of mice are as indicated. 
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agglutinated erythrocytes in the entire spleen as described pre- 
viously (7). The half-life of erythrocytes from the intermediate 
type mice was slightly shortened.  The results indicate that 
the anemic phenotype is not due to fluctuation of the hema- 
topoietic capacity of individual animals but rather to reduc- 
tion of the half-life of erythrocytes,  which is caused by the 
increase of the autoantibody. These results also indicate that 
destruction of erythrocytes is due to the autoantibodies bound 
to erythrocytes and that this severe anemia comes from AIHA. 
Individual H3L1 Mice Showed Both Deletion and Anergy of 
Autoreactive B Cells.  To investigate how autoreactive B ceils 
are regulated, the numbers of pre-B and B ceils in the spleen, 
lymph node,  and bone marrow of each H3L1  mouse were 
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Figure 5.  Deletion of autoreactive B ceils in H3L1 mice. Spleen, lymph node, and bone marrow cell suspensions of H3L1, H3, L1, and normal 
C57BL/6 mice were stained and analyzed by two color FACS  Q with anti-B220 (RA3-6B2), and either one of $54 and anti-lgM antibodies. Numbers 
orB, Id + B or pre-B cells were calculated by (% positive cells) x  (cells/organ). Id + B cell number was shown in H3L1 mice. Pre-B cells were detected 
as B220  + cells without surface IgM and IgG. Total bone marrow cell suspensions were obtained from two femurs and total lymph node cell suspen- 
sions were obtained from the inguinal, axillary, and submandibular regions for all mice. Each square represents one individual. Column I, H3L1 mice; 
column 2, H3 mice; column 3, L1 mice; column 4, normal C57BL/6  mice. 
75  Okamoto et al. estimated and compared with those of H3, L1, and normal 
C57BL/6 mice. In the spleen and lymph nodes of H3L1 mice, 
Id + B cells decreased generally and ratios of B cells to pre-B 
cells were also greatly reduced regardless of the hematocrit 
values as compared with H3 or L1, as well as normal mice 
(Fig. 5). This indicates that autoreactive B cells are deleted 
through recognition of the self-antigen  but not through simple 
expression of the rearranged Ig transgenes. In fact, the numbers 
of pre-B cells in spleens and lymph nodes of H3L1 mice are 
comparable with those of H3,  L1,  and normal mice.  The 
majority of the remaining B cells were not stained with the 
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Figure 6.  Two-color FACS  |  analyses of transgenic and normal mice. 
Spleen and bone marrow cell suspensions were stained and analyzed as 
described in Fig.  5.  Contour  maps are constructed  as Fig.  2. The per- 
centage  of positively  stained cells was indicated  in each compartment. 
anti-MAC-1  mAb, indicating that they are not Ly-1 B calls 
(23). It should be noted, however, that the degree of deletion 
is very different among individuals. The ratios of the number 
of B calls of the H3L1 mice to that of H3 or L1 mice varied 
between 0.01 and 1.0. On the other hand, in the bone marrow 
we cannot find any apparent differences in either the number 
of B calls or the ratio of B to pre-B cells between H3L1 mice 
and the other control mice. Fig. 6 shows the representative 
staining patterns of B cells in the spleen and bone marrow 
with the anti-IgM, anti-Id, and anti-B220 antibodies. In H3L1 
mice the staining patterns with anti-IgM antibody were al- 
most identical to those with the anti-Id mAb ($54). It should 
be noted that B cells in H3L1 mice are confined to the cells 
expressing low levels of surface antigen receptors. This sug- 
gests that autoreactive B cells with high levels of surface an- 
tigen receptors are preferentially deleted. Resultant B cells 
with the low density of surface antigen receptors are often 
observed in an anergic state (2,  24,  25). 
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Figure 7.  Poor correlation among deletion,  anergy, and autoantibody 
amounts. Each square represents one individual. (A) Reduced LPS-response 
of autoreactive B cells of 1-13L1 mice. Total spleen cells were cultured in 
vitro  in  the presence of 50 #g/ml LPS at three dit~nt  cell densities: 
105/ml, 106/ml, and 107/ml for 3 or 7 d. The highest Ig production by 
spleen cells of normal,  H3,  L1, and H3L1 mice were found in cultures 
containing 105, 105, 105, and 106 cells/ml, respectively, for 7 d. Amount 
of secreted IgM in the supernatants of LPS-induced in vitro cultures was 
divided by the number ofB cens in the culture which gave the most efficient 
Ig production.  In the case of H3L1 mice Id  + IgM/ld § B cell and in other 
cases total IgM/total B cell are shown. Column 1, H3L1 mice; column 
2, H3 mice; column 3, L1 mice; column 4, normal C57BL/6 mice. (B) 
No correlation between the e~tent of deletion and anergy of autoreactive 
B cells in H3L1 mice. LPS-induced Id + IgM per Id + B cell was plotted 
against remaining Id + B cell number in the spleen.  (C and/9) Amount 
of the autoantibody  in H3L1 mice is not directly  related with either B 
cell number,  LPS-responsive capacity of spleen cells. Id § B cell number 
(C) and LPS-induced Id + IgM per Id + B cell (D) were plotted  against 
MFI of FITC-anti-IgM bound  to autoantibodies  associated with ery- 
throcytes. 
76  A Transgenic Model of Autoimmune Hemolytic Anemia To confirm the anergic state of the remaining B cells, we 
investigated whether B cells in the spleen can be activated 
to produce the autoantibody by LPS  stimulation in vitro 
(26-28).  Total spleen cells  were used because it was very 
dif~cult to purify B cells enough for the culture from an in- 
dividual mouse. Secreted total IgM and Id + IgM in the su- 
pernatant were quantitated by ELISA. The IgM production 
value per B cell was calculated as an index of the reactivity 
to LPS (Fig.  7 A) and these values  of H3L1 mice were re- 
duced on the average to less than one-tenth of those of H3 
or L1 mice. The results indicate that remaining splenic B cells 
of H3L1 mice are anergized. By contrast, the same set of 
cells cultured with Con A  (2/~g/ml) or PHA (10 ~g/ml) 
did not produce any significant amounts of the autoantibody 
as compared with normal C57BL/6 mice (data not shown). 
The numbers of total T  cells,  CD4 + T  cells or CD8 + T 
cells did not correlate to the amounts of the autoantibody 
(data not shown). In addition, administration of LPS in vivo 
rendered tolerant mice severely anemic (our unpublished data). 
These results demonstrate that T cells do not secrete the au- 
toantibody enough to give rise to AIHA. 
Finally, we could not find any correlation between the ex- 
tent of clonal deletion and the degree of B cell anergy in each 
individual H3L1 mouse (Fig. 7 B). Taken together, these results 
show that both deletion and anergy are invoked to  get a 
tolerant state of potentially autoreactive B cells in H3L1 mice, 
but the relative contribution of the two mechanisms differs 
greatly in each individual. We failed to find a strong correla- 
tion between the amount of the autoantibody in blood and 
the degree of tolerance as assessed  by clonal deletion and anergy 
of potentially autoreactive B cells in the spleen (Fig.  7,  C 
and D). 
Escape of  Ly-1 B Cells  from Clonal Deletion.  We investigated 
whether Ly-1 B cells expressing the transgenes are rendered 
tolerant because they are considered distinct B lineage calls 
from the conventional B cell (29).  We recovered peritoneal 
cells in which Ly-1 B cells are rather enriched and enumer- 
ated Ly-1 B cells by surface staining with both anti-IgM (or 
anti-Id) and anti-MAC-1 antibodies (23).  The number of 
Id + Ly-1 B cells was almost equal to that of IgM + Ly-1 B 
cells in H3L1 mice (data not shown). The percentage and 
number of the Ly-1 B cells in H3L1 mice were not reduced 
as compared with those in H3, L1,  and normal C57BL/6 
mice. In contrast, conventional B cells in the peritoneal cavity 
were deleted as those in other peripheral lymphoid organs, 
resulting in relative enrichment of Ly-1 B cells (Table 1). We 
could not find a significant correlation of the amount of the 
autoantibody in blood in H3L1 mice with the number of 
Ly-1 B cells (data not shown). 
Discussion 
Previous transgenic models demonstrated that deletion and 
anergy of autoreactive B cells were actually invoked in vivo 
for the mechanism of B cell tolerance (2-4).  However, ap- 
parently either of the two mechanisms played a predominant 
role in each modal system: anergy for the anti-HEL (2) and 
anti-single-stranded DNA (3) antibodies; and deletion for 
the anti-MHC class I antibody (4).  In contrast, both dde- 
tion and anergy were invoked in the same individual of our 
transgenic mouse system, and furthermore, their relative con- 
tribution varied among the individuals with the same genetic 
background. These findings indicate that these mechanisms 
are not mutually exclusive even in an individual mouse for 
the combination of the same antigen and antibody. 
Why do tolerance mechanisms between previous transgenic 
systems and ours differ? Different antigen properties may be 
one possible cause. Two previous contrasting results, i.e., clonal 
deletion versus anergy, were explained by different concen- 
trations of self-antigens or by different forms, i.e.,  soluble 
versus membrane-bound (5). The high concentration of al- 
lotypic H-2 class I antigen expressed on the cell surface as 
Table  1.  Ly-1 B  Cells in the Peritoneal Cavity Escape from Deletion 
Mice  Percent Ly-IB  Percent conventional B  Ly-lB/conventional B 
H3L1  33  +_  4.8  6  _+  2.3  5.5 
(5.3  _+  1.3)  (1.2  _+ 0.6) 
H3  7  _+  1.3  12  _+ 0.8  0.6 
(1.6  _+ 0.5)  (2.9  _+ 0.7) 
L1  21  _+ 4.5  15  _+ 3.1  1.4 
(7.3  +_ 0.2)  (5.2  +_ 0.1) 
Normal  24  +  4.3  23  _+ 4.1  1.1 
C57BL/6  (3.9  _+ 0.5)  (3.7  _+ 0.2) 
Peritoneal cells were stained and analyzed by two-color FACS  |  with anti-Id (S54) or anti-IgM and anti-MAC-1 antibodies to discriminate Ly-1 
B cells from conventional B cells. Actual cell numbers  x  10 -s of each category are also shown in parentheses.  Cell number was calcuhted as described 
in the legend to Fig.  5.  Id + B cell numbers are shown in H3L1  mice.  Results are expressed  as the mean +_  SD of eight mice. 
77  Okamoto et al. a multivalent antigen may lead to clonal deletion, whereas 
the relatively low concentrations of HEL and single-stranded 
DNA in a soluble form may cause clonal anergy. The con- 
centration of the antigen recognized by the 4C8 mAb on 
an erythrocyte in our system can be estimated roughly from 
the amount of the autoantibodies bound on erythrocytes in 
the severely anemic H3L1 mice (Fig.  3 C). This concentra- 
tion does not seem less than that of the H-2 antigen on cells, 
suggesting that the concentration of the 4C8-recognized an- 
tigen may be high enough to cause deletion. It is hard, how- 
ever, to assess the effective or average concentration of the 
4CS-recognized antigen and compare it with that of the H-2 
class I antigen because expression of the 4C8-recognized an- 
tigen is rather restricted to the erythroid lineage whereas that 
of the class I  antigen is ubiquitous. 
Another aspect of the antigen expression that may trigger 
different mechanisms of self-tolerance is the onset of antigen 
expression during embryogenesis or timing of contact be- 
tween antigens and B lymphocytes. It is possible that B cells 
that had interacted with self-antigens in early stages of differen- 
tiation tend to be eliminated by donal deletion, whereas rel- 
atively mature B cells may be anergized by the same self- 
antigens (24).  Although no definite characterization of the 
4CS-recognized antigen is known, it is hard to believe that 
its expression, i.e., appearance of erythrocytes or their pro- 
genitors, is much later than that ofB lymphocytes, and such 
delay would allow B cells to escape tolerance. The timing 
and/or effective concentration of the antigen to encounter 
an individual B lymphocyte might vary in our transgenic 
system because of the restricted expression of the antigen, 
and the compartmental development of B lymphocytes and 
erythrocytes in the bone marrow. 
In contrast to the previous model systems, our transgenic 
model showed breakage of tolerance and wide variation of 
the phenotypes among the individuals with the same genetic 
background. Some of the H3L1 transgenic mice actually came 
down with severe AIHA. This is the first case of an autoim- 
mune disease in the transgenic animals carrying the Ig genes 
encoding the autoantibody. One of the reasons why we have 
been able to observe such breakage of tolerance might be that 
we had chosen an appropriate autoantibody that has a strong 
pathogenicity (6, 7). In fact, no pathogenic symptoms were 
found even through significant amounts of the anti-HEL an- 
tibody were found in blood in the double-transgenic mice 
of Goodnow et al.  (2).  The autoimmune symptoms corre- 
late well with the amount of autoantibody bound to the au- 
tologous erythrocytes. This indicates that most of the au- 
toantibody produced is actually pathogenic and not mutated 
to escape from tolerance. It is important to stress that our 
transgenic model system offers a more reasonable model for 
clinical autoimmune disease in variation among individuals, 
fluctuation during life (suggesting participation of environ- 
mental factors), and typical pathological symptoms. We will 
be able to assess the screening method for agents that treat 
or prevent AIHA and general autoimmune diseases using our 
model mouse. 
It is not likely that all B cells produce small amounts of 
the autoantibody in our transgenic mice because the total 
number of B cells in the spleen or peritoneal cavity is not 
related to the amounts of the autoantibody associated  with 
erythrocytes, although remaining B cells are anergic with 
downregulation of surface IgM. It is more likely that only 
a small fraction of B or plasma cells that escaped from the 
tolerance mechanism produced a relatively large amount of 
the autoantibody. It is interesting that the numbers of the 
Ly-1 B cells in the peritoneal cavity were not reduced in the 
H3L1 mice. This finding suggests that the Ly-1 B cells might 
have left the bone marrow rather early and developed separately 
from the conventional B cells. Ly-1 B cells may not have seen 
erythrocytes until they became mature B cells. Alternatively, 
Ly-1 B cells might have proliferated extensively after selec- 
tion. Since the presence of Ly-1 B cells in the peritoneal cavity 
alone does not cause the autoimmune symptoms, not all Ly-1 
B cells appear to produce the autoantibody. Most of them 
are likely to be anergized and only a fraction of them may 
produce the autoantibody. 
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